We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

13 hedge funds and large institutions have $2.18M invested in ProPhase Labs in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $1.46M → $2.18M (+$720K)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

19% less funds holding

Funds holding: 16 → 13 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$11K
2
UBS Group
UBS Group
Switzerland
+$6.37K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$807
4
BFA
BlackRock Fund Advisors
California
+$687

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$13K
2
VIP
Vantage Investment Partners
Missouri
-$7.86K
3
Bank of America
Bank of America
North Carolina
-$1.03K
4
TRCT
Tower Research Capital (TRC)
New York
-$1K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$635

PRPH Hedge Fund Activity: Q3 2016 in Review

13 of the 3,758 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q3 2016, worth a combined $2.18M — up 49% from $1.46M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PRPH and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $11K. The largest seller was Goldman Sachs, exiting entirely with an estimated $13K sold.

  • 13 institutional investors held ProPhase Labs (PRPH) as of Q3 2016, down from 16 in Q2 2016.
  • Funds reported $2.18M of ProPhase Labs stock for Q3 2016, up 49% quarter-over-quarter.
  • 0 funds opened new ProPhase Labs positions in Q3 2016 and 3 closed out, a net change of -3 holders.
  • The largest ProPhase Labs buyer in Q3 2016 was Renaissance Technologies, an estimated $11K added.
  • The largest ProPhase Labs seller in Q3 2016 was Goldman Sachs, an estimated $13K sold.

Based on aggregated 13F filings for Q3 2016.